Angiographic outcome in patients treated with deferred stenting after ST-segment elevation myocardial infarction—results from DANAMI-3-DEFER
- 25 August 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal: Acute Cardiovascular Care
- Vol. 11 (10) , 742-748
Abstract
Stent implantation during primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) occasionally results in flow disturbances and distal embolization, which may cause adverse clinical outcomes. Deferred stent implantation seems to reduce the impairment on myocardial function, although the mechanisms have not been clarified. We sought to evaluate whether deferred stenting could reduce flow disturbance in patients treated with primary PCI. Patients with STEMI included in the DANAMI-3-DEFER trial were randomized to deferred versus immediate stent implantation. The primary and secondary outcomes of this substudy were the incidences of slow/no reflow and distal embolization. A total of 1205 patients were included. Deferred stenting (n = 594) resulted in lower incidences of distal embolization [odds ratio (OR) 0.67, 95% confidence interval (CI) 0.46–0.98, P = 0.040] and slow/no reflow (OR 0.60, 95%CI 0.37–0.97, P = 0.039). In high-risk subgroups, the protective effect was greatest in patients >65 years of age (slow/no reflow: OR 0.36, 95% CI 0.17–0.72, P = 0.004 and distal embolization: OR 0.34, 95% CI 0.18–0.63, P = 0.001), in patients presenting with occluded culprit artery at admission (slow/no reflow: OR 0.33, 95% CI 0.16–0.65, P = 0.001 and distal embolization: OR 0.54, 95% CI 0.31–0.96, P = 0.036) and in patients with thrombus grade >3 (slow/no reflow: OR 0.37, 95% CI 0.20–0.67, P = 0.001 and distal embolization: OR 0.39, 95% CI 0.24–0.64, P < 0.001) with a significant P for interaction for all. Deferred stent implantation reduces the incidences of slow/no reflow and distal embolization, especially in older patients and in those with total coronary occlusion or high level of thrombus burden.Keywords
Funding Information
- Alfred Benzon Foundation
- Novo Nordisk Foundation
This publication has 23 references indexed in Scilit:
- A Randomized Trial of Deferred Stenting Versus Immediate Stenting to Prevent No- or Slow-Reflow in Acute ST-Segment Elevation Myocardial Infarction (DEFER-STEMI)JACC, 2014
- Immediate vs. delayed stenting in acute myocardial infarction: a systematic review and meta-analysisEuroIntervention, 2013
- Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot studyEuroIntervention, 2013
- Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial InfarctionCirculation: Cardiovascular Interventions, 2010
- Incidence and clinical consequences of distal embolization on the coronary angiogram after percutaneous coronary intervention for ST-elevation myocardial infarctionEuropean Heart Journal, 2008
- Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary InterventionCirculation, 2008
- No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary interventionAmerican Heart Journal, 2003
- Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarctionEuropean Heart Journal, 2002
- Combination Therapy With Abciximab Reduces Angiographically Evident Thrombus in Acute Myocardial InfarctionCirculation, 2001
- Coronary Angioplasty with or without Stent Implantation for Acute Myocardial InfarctionNew England Journal of Medicine, 1999